| Literature DB >> 21205581 |
Joe M Braun1, Amy E Kalkbrenner, Antonia M Calafat, John T Bernert, Xiaoyun Ye, Manori J Silva, Dana Boyd Barr, Sheela Sathyanarayana, Bruce P Lanphear.
Abstract
BACKGROUND: Prenatal bisphenol A (BPA) exposure may be associated with developmental toxicity, but few studies have examined the variability and predictors of urinary BPA concentrations during pregnancy.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21205581 PMCID: PMC3018492 DOI: 10.1289/ehp.1002366
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1Distribution of prenatal BPA (A), creatinine-standardized BPA (B), and creatinine concentrations (C) during the latter two-thirds of pregnancy. Blue dots represent median values, black and white hatch marks the 25th and 75th percentiles, and whiskers the 5th and 95th percentiles.
Proportion of variability in serial urinary BPA concentrations attributed to within-woman and between-woman variation.a
| Components of variance | |||
|---|---|---|---|
| Outcome in mixed model | Between-woman (SE) | Within-woman (SE) | ICC |
| Unstandardized BPA concentrations | |||
| 16 and 26 weeks | 0.06 (0.01) | 0.15 (0.01) | 0.28 |
| 26 weeks and birth | 0.05 (0.01) | 0.15 (0.01) | 0.26 |
| 16 weeks, 26 weeks, and birth | 0.05 (0.01) | 0.15 (0.01) | 0.25 |
| Creatinine-standardized BPA concentrations | |||
| 16 and 26 weeks | 0.01 (0.01) | 0.11 (0.01) | 0.11 |
| 26 weeks and birth | 0.01 (0.01) | 0.10 (0.01) | 0.12 |
| 16 weeks, 26 weeks, and birth | 0.01 (0.00) | 0.11 (0.01) | 0.10 |
| Creatinine concentrations | |||
| 16 and 26 weeks | 0.06 (0.01) | 0.06 (0.00) | 0.49 |
| 26 weeks and birth | 0.03 (0.01) | 0.08 (0.01) | 0.30 |
| 16 weeks, 26 weeks, and birth | 0.04 (0.01) | 0.08 (0.00) | 0.35 |
Includes only women who have all three urinary BPA measurements (n = 332).
Computed by dividing the between-woman variation by the total variation (between-woman plus within-woman).
GM mean urinary BPA and creatinine concentrations during pregnancy according to the time of urine collection and fasting time.
| BPA (μg/L) | Creatinine (mg/dL) | Creatinine-standardized BPA (μg/mg) | |||
|---|---|---|---|---|---|
| Variable | 16 weeks | 26 week | GM (GSE) | GM (GSE) | GM (GSE) |
| Time of day | |||||
| 0700–0859 | 19 | 32 | 1.8 (1.2) | 91.6 (1.1) | 2.1 (1.1) |
| 0900–1059 | 90 | 116 | 1.7 (1.1) | 90.3 (1.1) | 1.9 (1.1) |
| 1100–1259 | 84 | 48 | 1.5 (1.1) | 94.0 (1.1) | 1.7 (1.1) |
| 1300–1459 | 73 | 81 | 2.0 (1.1) | 95.0 (1.1) | 2.2 (1.1) |
| 1500–1659 | 66 | 56 | 1.9 (1.1) | 79.8 (1.1) | 2.5 (1.1) |
| 1700–1900 | 27 | 5 | 2.1 (1.2) | 94.6 (1.1) | 2.3 (1.2) |
| Fasting time | |||||
| 0 to < 2 hr | 51 | 47 | 1.7 (1.7) | 85.7 (1.1) | 2.1 (1.1) |
| 2 to < 4 hr | 83 | 90 | 1.6 (1.6) | 83.8 (1.1) | 2.1 (1.1) |
| 4 to < 6 hr | 131 | 107 | 1.7 (1.7) | 86.9 (1.1) | 2.1 (1.1) |
| 6 to < 12 hr | 45 | 30 | 2.9 (2.9) | 130.6 (1.1) | 2.1 (1.1) |
| 12 to 24 hr | 22 | 26 | 1.9 (1.9) | 104.7 (1.1) | 1.8 (1.1) |
Log10-transformed urinary BPA, creatinine, or creatinine-standardized BPA concentrations at 16 and 26 weeks of gestation are the outcome in a linear mixed model.
GM urinary BPA concentrations (μg BPA/g creatinine) according to demographic, perinatal, and maternal factors.a
| Variable | GM (GSE) | Ratio (95% CI) | |
|---|---|---|---|
| Maternal race | |||
| Non-Hispanic white | 237 (62) | 2.1 (1.0) | Reference |
| Non-Hispanic black | 120 (31) | 2.1 (1.0) | 1.01 (0.90–1.14) |
| Other | 26 (7) | 1.9 (1.1) | 0.94 (0.75–1.16) |
| Maternal education (years) | |||
| > 12 | 288 (75) | 2.0 (1.0) | Reference |
| 12 | 54 (14) | 2.3 (1.1) | 1.14 (0.98–1.33) |
| < 12 | 41 (11) | 2.4 (1.1) | 1.19 (1.00–1.41) |
| Marital status | |||
| Married | 248 (65) | 2.0 (1.0) | Reference |
| Unmarried | 134 (35) | 2.2 (1.0) | 1.08 (0.96–1.20) |
| Maternal age (years) | |||
| 25–34 | 230 (59) | 2.0 (1.0) | Reference |
| < 25 | 96 (25) | 2.1 (1.1) | 1.05 (0.92–1.19) |
| > 35 | 62 (16) | 2.0 (1.1) | 0.97 (0.84–1.12) |
| Income (per year) | |||
| > $80,000 | 103 (28) | 2.0 (1.1) | Reference |
| $40,000 to < $80,000 | 120 (32) | 2.0 (1.0) | 1.04 (0.91–1.19) |
| $20,000 to < $40,000 | 65 (17) | 2.0 (1.1) | 1.02 (0.86–1.20) |
| < $20,000 | 87 (23) | 2.2 (1.1) | 1.13 (0.97–1.31) |
| Depression Score at 20 weeks | |||
| Minimal (< 13) | 290 (78) | 2.1 (1.0) | Reference |
| Moderate (13–19) | 54 (14) | 2.1 (1.1) | 1.01 (0.86–1.18) |
| Severe (> 19) | 30 (8) | 1.9 (1.1) | 0.90 (0.74–1.09) |
| Parity | |||
| 0 | 171 (44) | 2.1 (1.0) | Reference |
| 1 | 123 (32) | 2.0 (1.0) | 0.97 (0.86–1.09) |
| > 1 | 92 (24) | 2.1 (1.1) | 0.98 (0.86–1.12) |
| Maternal IQ (per 10 points) | 318 | — | 0.97 (0.93–1.01) |
| Child sex | |||
| Female | 208 (54) | 2.1 (1.0) | Reference |
| Male | 180 (46) | 2.0 (1.0) | 0.96 (0.86–1.06) |
Ratios are the exponentiated beta coefficients from a linear mixed model with 16-week, 26-week, and birth creatinine-standardized BPA measurements as the outcome. Ratios represent the multiplicative difference in creatinine-standardized urinary BPA concentrations from the reference category. Each predictor is run in a separate model.
At 16-week visit.
GM urinary BPA concentrations (μg BPA/g creatinine) according to dietary and occupational factors.a
| Variable | GM (GSE) | Unadjusted ratio (95% CI) | Adjusted ratio (95% CI) | |
|---|---|---|---|---|
| Frequency of fish consumption | ||||
| Not at all | 57 (15) | 2.1 (1.1) | Reference | Reference |
| < Once/month | 113 (30) | 2.1 (1.0) | 1.01 (0.86–1.18) | 1.03 (0.88–1.20) |
| 1–3 times/month | 131 (34) | 2.0 (1.0) | 0.94 (0.80–1.10) | 0.97 (0.83–1.13) |
| Weekly or more | 77 (19) | 2.1 (1.1) | 1.00 (0.84–1.20) | 1.04 (0.87–1.24) |
| Frequency of canned fruit consumption | ||||
| Not at all | 45 (12) | 2.0 (1.1) | Reference | Reference |
| < Once/month | 55 (14) | 2.0 (1.1) | 1.04 (0.86–1.26) | 1.04 (0.85–1.26) |
| 1–3 times/month | 91 (24) | 2.0 (1.1) | 1.03 (0.86–1.22) | 1.01 (0.85–1.21) |
| 1–3 times/week | 96 (25) | 2.1 (1.1) | 1.05 (0.89–1.25) | 1.05 (0.88–1.25) |
| 4–6 times/week | 50 (13) | 2.2 (1.1) | 1.13 (0.92–1.39) | 1.13 (0.92–1.39) |
| ≥ Once/day | 45 (12) | 2.2 (1.1) | 1.09 (0.89–1.34) | 1.08 (0.88–1.33) |
| Frequency of canned vegetable consumption | ||||
| Not at all | 17 (4) | 1.6 (1.1) | Reference | Reference |
| < Once/month | 30 (8) | 2.0 (1.1) | 1.24 (0.90–1.69) | 1.42 (1.03–1.97) |
| 1–3 times/month | 58 (15) | 2.1 (1.1) | 1.29 (0.97–1.71) | 1.44 (1.07–1.93) |
| 1–3 times/week | 133 (35) | 2.0 (1.0) | 1.22 (0.93–1.59) | 1.38 (1.04–1.83) |
| 4–6 times/week | 88 (23) | 2.2 (1.1) | 1.38 (1.05–1.82) | 1.56 (1.17–2.09) |
| ≥ Once/day | 56 (15) | 2.3 (1.1) | 1.39 (1.04–1.86) | 1.52 (1.13–2.06) |
| Frequency of fresh fruit and vegetable consumption | ||||
| > Once/day | 77 (20) | 2.0 (1.0) | Reference | Reference |
| About once a day | 73 (19) | 1.7 (1.2) | 0.84 (0.57–1.22) | 1.02 (0.88–1.19) |
| 4–6 times/week | 104 (27) | 2.2 (1.1) | 1.09 (0.94–1.25) | 1.07 (0.93–1.23) |
| 1–3 times/week | 83 (22) | 2.0 (1.1) | 0.97 (0.84–1.13) | 0.96 (0.82–1.12) |
| 1–3 times/month | 39 (10) | 2.2 (1.1) | 1.09 (0.89–1.35) | 1.03 (0.83–1.29) |
| < Once/month or not at all | 6 (2) | 2.4 (1.2) | 1.22 (0.84–1.76) | 1.19 (0.80–1.77) |
| Vegetarian | ||||
| No | 363 (95) | 2.1 (1.0) | Reference | Reference |
| Partial | 14 (4) | 2.4 (1.1) | 1.16 (0.88–1.52) | 1.17 (0.89–1.55) |
| Strict | 5 (1) | 1.3 (1.3) | 0.64 (0.41–1.00) | 0.64 (0.40–1.00) |
| Organic fruit and vegetable consumption | ||||
| None | 225 (59) | 2.1 (1.0) | Reference | Reference |
| Less than half | 122 (32) | 2.1 (1.1) | 1.00 (0.89–1.12) | 1.03 (0.91–1.16) |
| More than Half | 32 (8) | 2.0 (1.1) | 0.99 (0.81–1.21) | 0.98 (0.79–1.21) |
| Occupation | ||||
| Unemployed | 84 (22) | 1.9 (1.1) | Reference | Reference |
| Cashier | 17 (4) | 2.8 (1.1) | 1.32 (1.00–1.75) | 1.15 (0.84–1.57) |
| Health care worker | 57 (15) | 2.1 (1.1) | 1.00 (0.84–1.19) | 1.04 (0.87–1.25) |
| Food service | 16 (4) | 2.1 (1.2) | 1.01 (0.74–1.39) | 1.02 (0.74–1.40) |
| Industrial worker | 14 (4) | 1.2 (1.2) | 0.59 (0.40–0.87) | 0.61 (0.41–0.90) |
| Teacher | 37 (10) | 1.8 (1.1) | 0.84 (0.69–1.03) | 0.89 (0.71–1.12) |
| Office worker | 118 (31) | 2.1 (1.0) | 1.00 (0.87–1.15) | 1.06 (0.91–1.24) |
| Sales or service worker | 36 (9) | 2.1 (1.1) | 1.00 (0.82–1.21) | 1.04 (0.85–1.28) |
| Other | 2 (1) | 1.2 (1.4) | 0.59 (0.31–1.14) | 0.60 (0.31–1.18) |
Ratios are the exponentiated beta coefficients from a linear mixed model with 16-week, 26-week, and birth creatinine-standardized BPA measurements as the outcome. Ratios represent the multiplicative difference in creatinine-standardized urinary BPA concentrations from the reference category. Each predictor is run in a separate model.
At 16-week visit.
Adjusted for maternal age, race, education, household income, and marital status.
GM urinary BPA concentrations (μg BPA/g creatinine) by biomarkers of tobacco smoke and phthalates exposure.a
| Variable | GM (GSE) | Unadjusted ratio (95% CI) | Adjusted ratio (95% CI) | |
|---|---|---|---|---|
| Categorical serum cotinine concentrations | ||||
| Unexposed (< 0.015 ng/mL) | 112 (30) | 1.9 (1.0) | Reference | Reference |
| Secondhand smoker (0.015–3 ng/mL) | 221 (59) | 2.2 (1.0) | 1.17 (1.05–1.30) | 1.19 (1.05–1.35) |
| Active smoker (> 3 ng/mL) | 43 (11) | 2.3 (1.1) | 1.23 (1.03–1.47) | 1.27 (1.01–1.58) |
| Phthalates | ||||
| Low-molecular-weight phthalates | 387 | — | 1.07 (0.97–1.18) | 1.06 (0.96–1.18) |
| High-molecular-weight phthalates | 387 | — | 1.28 (1.16–1.40) | 1.26 (1.15–1.39) |
| DEHP metabolites | 387 | — | 1.24 (1.14–1.36) | 1.24 (1.13–1.35) |
Ratios are the exponentiated beta coefficients from a linear mixed model with 16-week, 26-week, and birth creatinine-standardized BPA measurements as the outcome. Ratios represent the multiplicative difference in creatinine-standardized urinary BPA concentrations from the reference category. Each predictor is run in a separate model.
At 16-week visit.
Adjusted for maternal age, race, education, household income, and marital status.
Low-molecular-weight phthalates include MBP (monobutyl phthalate), MEP (monoethyl phthalate), and MIBP (monoisobutyl phthalate). High-molecular-weight phthalates include MBzP (monobenzyl phthalate), MEHP (mono-2-ethylhexyl phthalate), MECPP [mono-(2-ethyl-5-carboxypentyl) phthalate], MEHHP [mono-(2-ethyl-5-hydroxylhexyl) phthalate], MEOHP [mono-(2-ethyl-5-oxohexyl) phthalate], and MCPP (mono-3-carboxypropyl phthalate). DEHP metabolites include MECPP, MEHHP, MEOHP, and MEHP. All phthalates concentrations are creatinine standardized.